Ernexa Therapeutics joins Virtual Investor Closing Bell Series webcast

ERNA•2026-10-12

Ernexa Therapeutics will join the Virtual Investor Closing Bell Series on Oct. 15, 2026, at 4:00 p.m. ET, and plans to discuss its cell-therapy platform strategy and lead program ERNA-101.

1. Webcast plans

Ernexa Therapeutics will join the Virtual Investor Closing Bell Series on Oct. 15, 2026, at 4:00 p.m. ET. Management plans to provide a corporate update covering its cell-therapy platform strategy and progress of lead program ERNA-101 toward clinical development.

Ernexa Therapeutics joins Virtual Investor Closing Bell Series webcast

1. Webcast plans

Related News

Penguin Solutions grants new CFO Stephen Cumming 33,502 RSUs and 48,818 performance RSUs as inducement awards

Organogenesis says PREPARE RCT shows PuraPlyAM boosts 12-week closure rates in hard-to-heal diabetic foot ulcers

LeMaitre Vascular to release Q3 2026 earnings results after market close

US stocks end mixed ahead of earnings, data

Shutterstock schedules third-quarter 2026 earnings release, conference call